Organization | Triệu, Nguyễn Thị, M.D.

Triệu, Nguyễn Thị, M.D. Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial

2009

NCT02618148

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2020

Timeline

NOW

Now

Alternative names

Trieu, Nguyen Thi, M.D. | Triệu, Nguyễn Thị, M.D.

Active Ingredients

Drugs in Phase 4 Trials (9)

adenosma glutinosum (2 trials)

dioscorea villosa tuber (1 trial)

dydrogesterone (gynorest) (1 trial)

eclipta prostrata (2 trials)

estrogen (1 trial)

impatiens balsamina (1 trial)

phyllanthus urinaria (2 trials)

pregnenolone (1 trial)

pyridoxal phosphate anhydrous (1 trial)

Drugs in Phase 2 Trials (1)

anticov-220 (1 trial)

Drugs in Other Trials (3)

sb-1121 (1 trial)

tenofovir (viread) (1 trial)

vitamin c (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Leiomyoma (Phase 4)

Myofibroma (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 7
# of Trial APIs: 13